Hong Kong Pharma Digital Technology Holdings Limited(HKPD)Earnings, Financials & Key Ratios
HKPD•NASDAQ
$0.43
Price updated Jul 7, 2026
SectorIndustrialsIndustryFreight & LogisticsSub-IndustryContract Logistics and Specialized Warehousing
AboutHong Kong Pharma Digital Technology Holdings Ltd. engages in providing pharmaceutical cross-border e-commerce supply chain services. It focuses on cross-border pharmaceutical warehousing, cross-border OTC registration and import, and OTC product wholesale services. The company was founded by Lap Sun Wong on August 17, 2023 and is headquartered in Hong Kong.Show more
- Revenue$20M+21.7%
- EBITDA$1M-52.4%
- Net Income-$27K-102.0%
- EPS (Diluted)-0.00-101.7%
- Gross Margin11.89%-44.2%
- EBITDA Margin5.93%-60.9%
- Operating Margin0.65%-93.3%
- Net Margin-0.13%-101.7%
- ROE-0.59%-101.1%
HKPD Price & Volume
Hong Kong Pharma Digital Technology Holdings Limited (HKPD) stock price & volume — 10-year historical chart
Loading chart...
Severe Margin Erosion Challenges Operational Viability
Investment Thesis • Updated 2025Q4
VerdictNegative
Growth:Decelerating
Profitability:Negative
Financial:Vulnerable
Cash Flow:Burning
Primary Risk:Liquidity and Regulatory Volatility
Key Thesis Takeaways
- Hong Kong Pharma Digital Technology Holdings Limited faces a critical inflection point as its core pharmaceutical logistics model struggles with a 4.7% revenue contraction and a collapse in gross margins to 5.5% in 2025Q4.
- The company's transition to a negative operating margin of 9.7% suggests that its current asset-heavy infrastructure is failing to scale effectively against rising procurement costs.
- Investors should monitor the firm's ability to stabilize its $748.7K cash position, as the current trajectory of negative net income and cash burn poses significant risks to long-term solvency.
Verdict Logic
the company's inability to maintain profitability, evidenced by a net loss of $855.6K in 2025Q4, suggests that the current business model is not yet sustainable.
HKPD Growth Metrics
Hong Kong Pharma Digital Technology Holdings Limited (HKPD) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR
Revenue CAGR
10 Years-
5 Years-
3 Years-
TTM-
Profit CAGR
10 Years-
5 Years-
3 Years-
TTM-
EPS CAGR
10 Years-
5 Years-
3 Years-
TTM-
Return on Capital
10 Years58.24%
5 Years58.24%
3 Years58.24%
Last Year2.2%
Peers Comparison
Key metrics vs top competitors for Hong Kong Pharma Digital Technology Holdings Limited (HKPD)
| Company | Price | Market Cap | P/E Ratio | Rev Growth (1Y) | Net Margin | ROE | Div Yield |
|---|---|---|---|---|---|---|---|
| $0.43 | $4.7M | -142.33 | 21.72% | -0.13% | -0.59% | — | |
| $3.68 | $2.12M | -0.59 | 28.47% | -94.07% | -22.04% | — | |
| $0.99 | $3.22M | -1.47 | -70.11% | -33.27% | -28.25% | — | |
| $1.65 | $537.3M | -5.32 | -30.65% | -146.01% | -0.11% | — | |
| $4.47 | $1.55M | -0.07 | -97.89% | -24.73% | -102.39% | — | |
| $5.67 | $1.97B | -9.45 | 698.96% | -102.06% | -44.1% | — |
Compare HKPD vs Peers
Hong Kong Pharma Digital Technology Holdings Limited (HKPD) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
Get notified when HKPD posts new earnings or crosses analyst targets
Free. No account needed. Unsubscribe any time.
HKPD Frequently Asked Questions
Hong Kong Pharma Digital Technology Holdings Limited (HKPD) stock FAQ — growth, dividends, profitability & financials explained
Growth & Financials
What is Hong Kong Pharma Digital Technology Holdings Limited's revenue?
Hong Kong Pharma Digital Technology Holdings Limited (HKPD) reported $20.3M in revenue for fiscal year 2025. This represents a 62% increase from $12.6M in 2023.
How fast is Hong Kong Pharma Digital Technology Holdings Limited growing?
Hong Kong Pharma Digital Technology Holdings Limited (HKPD) grew revenue by 21.7% over the past year. This is strong growth.
Is HKPD profitable?
Hong Kong Pharma Digital Technology Holdings Limited (HKPD) reported a net loss of $0.0M for fiscal year 2025.
Dividend & Returns
What is HKPD's return on equity?
Hong Kong Pharma Digital Technology Holdings Limited (HKPD) has a return on equity (ROE) of -0.6%. Negative ROE indicates the company is unprofitable.
What is Hong Kong Pharma Digital Technology Holdings Limited's free cash flow?
Hong Kong Pharma Digital Technology Holdings Limited (HKPD) generated $0.4M in free cash flow for fiscal year 2025. Positive FCF indicates the company can fund dividends, buybacks, or reinvestment.